to Content

04: Gene therapy – intervention in nature or future hope

-
Hauptschule
Breakout / Working Group
German and English language

For 20 years scientists have been working on gene therapies. Some new compounds for rare diseases have been approved. The application of these new technologies is inspiring much hope! However, many questions remain. What further potential do these applications contain? Which diseases will be cured? Is this personalized medicine? Who will bear the development costs and how expensive will such costs be? Which national health systems can afford these high-price compounds? What are the regulatory topics that should be discussed? Finally, we will take a look at the ethical questions surrounding these developments.

Speakers

Member of the Provincial Government of Lower Austria for Economic Affairs, Tourism, Technology and Sports, St. Pölten Introduction
Professor for Moral Theology and Medical Ethics, Department Systematic Theology, University of Vienna
President and CEO, Medley Genomics, Providence, RI
Senior Expert, Analytics of Biological Medicinal Products, AGES - Austrian Agency for Health and Food Safety, Ltd.; Austrian Federal Office for Safety in Health Care, Vienna
Head, Research Gene Therapy EU, Shire Austria GmbH, Orth an der Donau
Head of Department, Company and Technology, ecoplus. The Business Agency of Lower Austria, St. Pölten Chair
Assistant to the Department and Project Manager, Company and Technology, ecoplus. The Business Agency of Lower Austria, St. Pölten Coordination

Downloads

Dr.in Petra BOHUSLAV

Member of the Provincial Government of Lower Austria for Economic Affairs, Tourism, Technology and Sports, St. Pölten

1991 Economic sciences (tourism, human resource management), WU (Vienna University of Economics and Business)
1991-1994 Marketing manager, Railtours Austria
1995 Head of Marketing and Sales Department, Rogner-Thermen Blumau, Stegersbach
1996-2001 Chief Executive Officer, Archäologiepark Carnuntum Ltd.
2001-2004 Chief Executive Officer, Congress Casino Baden
2004-2008 Minister for Labour, Social Affairs, Sports, Culture, Provincial Government of Lower Austria, St. Pölten
2008-2009 Minister for Youth, Education and Sports, Provincial Government of Lower Austria, St. Pölten
since 2009 Minister for Economic Affairs, Tourism, Technology and Sports, Provincial Government of Lower Austria, St. Pölten

Dr. med Dr. theol. Mag. pharm. Matthias BECK

Professor for Moral Theology and Medical Ethics, Department Systematic Theology, University of Vienna

1976-1981 Studium der Pharmazie, Westfälische Wilhelms Universität Münster
1980-1987 Studium der Humanmedizin, WWU Münster und LMU München
1985 Studienaufenthalt, Medical College, Srinagar
1988 Promotion zum Dr.med. in der Dermatologie, WWU Münster
1987-1989 Philosophie, Hochschule für Philosophie S.J. München
1990-1993 Theologie, (röm.-kath.) LMU München
1994-1998 Promotionsarbeit in Theologie
1999 Promotion zum Dr. theol.
2002 Forschungsaufenthalt, Georgetown University, Washington
2007 Habilitation, Moraltheologie und Medizinethik, Universität Wien
seit 2007 Außerordentlicher Universitäts-Professor, Moraltheologie und Medizinethik, Universität Wien

Ph.D. Patrice MILOS

President and CEO, Medley Genomics, Providence, RI

1980-1984 Ph.D., Biology, Rensselaer Polytechnic Institute, NY
1984-1987 Post-Doctoral Fellow, The Biological Laboratories, Harvard University, MA
1987-1990 Post-Doctoral Fellow, Brown University, RI
1993-2007 Executive Director, Global Research & Development, Pfizer Inc., CT
1993-2007 Executive Director, Translational and Molecular Medicine, Pfizer Inc., CT.
2007-2011 Senior Vice President; CSO, Helicos BioSciences, MA
2011-2013 Site Head, Centers for Therapeutic Innovation, Pfizer Inc., MA
2013-2016 President, CEO, Claritas Genomics, MA
since 2015 Scientific Advisor SeqLL - ULTRAPLACAD - Baby's First Test
since 2016 Co-Founder, President and CEO, Medley Genomics, RI
since 2017 Board of Directors, MedMates, RI BIO Affiliate, RI
since 2018 Scientific Advisor, Atlas Genetics, Trowbridge

Dr. Dieter PULLIRSCH

Senior Expert, Analytics of Biological Medicinal Products, AGES - Austrian Agency for Health and Food Safety, Ltd.; Austrian Federal Office for Safety in Health Care, Vienna

2002-2006 Ph.D., Institute of Molecular Pathology, Vienna
2007-2008 Postdoctoral Research, Pasteur Institute, Paris
2008-2010 Postdoctoral Resarch, University of Vienna
since 2010 Assessor for Batch Release, AGES MEA - Austrian Medicines and Medical Devices Agency, Vienna
since 2012 Deputy Head, Department Analytics of Biological Medicinal Products, Vienna
since 2014 Senior Expert, AGES - Austrian Agency for Health and Food Safety, Ltd., Vienna

Ph.D. Hanspeter ROTTENSTEINER

Head, Research Gene Therapy EU, Shire Austria GmbH, Orth an der Donau

1998 Ph.D. in Biochemistry, University of Vienna
1999-2002 Postdoctoral Research, Freie Universität Berlin
2002 Assistant Professor, Ruhr-Universität Bochum
2003-2007 Professor in Physiological Chemistry, Bochum
2007-2014 Head of Recombinant Products, Global Research, Baxter, Vienna
2014-2016 Research Gene Therapy, Baxalta Innovations, Vienna
since 2016 Head, Research Gene Therapy EU, Shire Austria GmbH, Orth an der Donau

Dipl.-Ing. Claus ZEPPELZAUER

Head of Department, Company and Technology, ecoplus. The Business Agency of Lower Austria, St. Pölten

 Studium der Lebensmittel- und Biotechnologie, Universität für Bodenkultur Wien
1998-2000 Brauereileiter, Braumeister und stellvertretender Geschäftsführer, 1. Wiener Gasthofbrauerei
2000-2001 Senior Consultant, Czipin & Proudfoot, früher Czipin & Partner, Internationale Produktivitätsberatung
2001-2003 Leiter, Abteilung Research & Development, Melbrosin International GmbH & Co KG
2003-2004 Gründer und Inhaber, Life Science Project Management, Unternehmensberatung für externe Projektleitung von interdisziplinären F&E - Projekten
seit 2004 Technopolemanager, Tulln, ecoplus. Niederösterreichs Wirtschaftsagentur GmbH
seit 2006 Geschäftsfeldleiter, Technopole, ecoplus. Niederösterreichs Wirtschaftsagentur GmbH
  Verantwortlich für die Geschäftsfelder Cluster Niederösterreich, Internationalisierung und Technopole
seit 2007 Bereichsleiter, Unternehmen & Technologie, ecoplus. Niederösterreichs Wirtschaftsagentur

MBA Karin HERZOG

Assistant to the Department and Project Manager, Company and Technology, ecoplus. The Business Agency of Lower Austria, St. Pölten

1983-1988 Commerical education
1988-1990 Studies, textile chemistry, Vienna
1990-1991 Laboratory technician, textile chemistry, EYBL, Krems
1991-1992 Export manager, Plant engineering-Business, Norbert Schaller GmbH, Vienna
1993-2008 Assistant, general plant and production management, ARDEX Loosdorf
2010-2013 Postgraduate studies, Event Management (in-service training)
since 2008 Assistant; Division Head, Company & Technology; project manager, Interreg Europe Projects, Technopole Lower Austria and technology events, ecoplus. The Business Agency of Lower Austria, St. Pölten

Technology Symposium

show timetable

23.08.2018

11:00 - 12:00Open doors: #ART TECCulture
11:00 - 12:00Start of exhibition TEC-Xperience RoomPartner
13:00 - 13:10Welcome and openingPlenary
13:10 - 14:00RTI TalkPlenary
14:20 - 15:40Precision medicine - medicine's solution to diversity?Plenary
16:00 - 17:30Nutrition sciencePlenary
20:15 - 21:15Tickets to Berlin: Falling Walls Lab Austria & Summer School on EntrepreneurshipPlenary
21:15 - 22:30Die Presse Career lounge for students and young professionalsPlenary
21:30 - 23:30Evening ReceptionSocial

24.08.2018

08:30 - 09:00TU Austria Innovation Marathon: ideas made to order - 24 hours nonstopPlenary
09:00 - 18:00Junior Alpbach - Science and technology for young peopleBreakout
09:00 - 15:00Ö1 Children's University Alpbach - Science and Technology for KidsBreakout
09:15 - 10:30Seattle never sleeps: a young, booming innovation hub as this year’s guest at the Technology SymposiumPlenary
10:45 - 12:15Our digital future - how human will it be?Plenary
12:30 - 13:00Lunch snacks for the participants of the breakout sessionsSocial
13:00 - 18:00Breakout Session 01: The contest for key technologies - Europe's potentials?Breakout
13:00 - 18:00Breakout Session 02: Digitization and diversity - an opportunity for business locationsBreakout
13:00 - 18:00Breakout Session 03: Inequality and resilience in the digital economyBreakout
13:00 - 18:00Breakout Session 04: Gene therapy - intervention in nature or future hopeBreakout
13:00 - 18:00Breakout Session 05: Next-generation batteries: European leading-edge technology to leverage electromobilityBreakout
13:00 - 18:00Breakout Session 06: EU NIS directive and NIS act - what now?Breakout
13:00 - 18:00Breakout Session 07: Industrial energy revolution: resilience through innovation?Breakout
13:00 - 18:00Breakout Session 08: Digital literacy for allBreakout
13:00 - 18:00Breakout Session 09: Consequences of digital monocultures on societiesBreakout
13:00 - 18:00Breakout Session 10: Future disruptive technologies: challenges for modern societiesBreakout
13:00 - 18:00Breakout Session 11: Digital life in a physical world: rethinking digitizationBreakout
13:00 - 18:00Breakout Session 12: The renewability of societal resourcesBreakout
13:00 - 18:00Breakout Session 13: Resilience - how societies can cope with crisesBreakout
18:30 - 19:30Global Talk: #MakeInIndia - India on the fast track?Plenary

25.08.2018

09:00 - 10:30Cyborgs - when technology gets under your skinPlenary
10:50 - 11:50The resilience of democracy and democratic mediaPlenary
11:50 - 12:15Public service strategies in times of digital disruptionPlenary
12:30 - 13:15The physics of everyday thingsPlenary
13:00 - 14:00Snack receptionSocial